The interaction between neuroleptic treatment and sociotherapeutic approach in chronic schizophrenics. Investigations with haloperidol, penfluridol and pimozide.
In the modern treatment of chronic schizophrenic patients two major trends can be outlined: sociotherapy and psychopharmacotherapy. Therefore it is an important question whether these two therapeutic approaches interact in a positive or a negative way. Selected examples of experiments about the interaction of haloperidol, penfluridol and pimozide with sociotherapy are given and discussed. It is also demonstrated that the learning capacity of the patients depends on the particular type of neuroleptic.
D003158:Community Psychiatry; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D010352:Patient Dropouts; D010395:Penfluridol / Q000627:therapeutic use*; D010868:Pimozide / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D010919:Placebos; D011613:Psychotherapy; D012008:Recurrence; D012559:Schizophrenia / Q000188:drug therapy / Q000628:therapy*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D010880:Piperidines; D010919:Placebos; D014149:Tranquilizing Agents; D010868:Pimozide; D010395:Penfluridol; D006220:Haloperidol